Clinical trial
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment…
NCT00123747 · AHS Cancer Control Alberta, Other · Completed
Key facts
| NCT number | NCT00123747 |
|---|---|
| Title | Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer |
| Official title | A Phase II Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer |
| Lead sponsor | AHS Cancer Control Alberta, Other |
| Collaborators | Cross Cancer Institute |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lung Neoplasms |
| Intervention type | Procedure |
| Interventions | Positron Emission Tomography (PET) scan Imaging |
| Enrollment | 23 |
| Start date | Aug 1, 2005 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 26, 2005 |
| Last update posted | Feb 25, 2016 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: